Glenmark Pharmaceuticals, a global pharmaceutical company announced positive results for GSP 301, an investigational fixed-dose combination of mometasone furoate (25...
Read moreMedigene had contracted Mitsui Norin since 2005 for manufacturing and supplying the active pharmaceutical ingredient (API) of Veregen®. Based on...
Read moreIcertis, the leading provider of enterprise contract management in the cloud announced an upgrade to the Icertis Clinical Trial Agreement...
Read moreRecipharm, the contract development and manufacturing organisation (CDMO), has entered into a long term agreement with Sato Pharmaceutical Co. for...
Read moreBioSig Technologies, Inc , a medical device company developing the PURE EP(TM) System, a proprietary platform designed to address an...
Read moreJazz Pharmaceuticals plc announced that the first patient has been enrolled in a Phase 3 clinical study evaluating JZP-258, an...
Read moreCatalyst Pharmaceuticals, Inc. , a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare neuromuscular and...
Read moreEMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, in the US and Canada, and Pfizer Inc. announced that...
Read morePMV Pharmaceuticals, Inc., a leader in the discovery and development of p53-targeted small molecule drugs for the treatment of cancer...
Read moreApitope, the drug discovery and development company focused on treating the underlying cause of autoimmune diseases, announces positive results from...
Read morePharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.